Tiny drops, big questions: new study eyes steroid safety in preterm infants

NCT ID NCT05387941

First seen May 02, 2026 · Last updated May 23, 2026 · Updated 5 times

Summary

This study looked at how steroid eye drops are absorbed and broken down in premature babies who have retinopathy of prematurity, an eye condition that can lead to blindness. Eleven infants born before 30 weeks of pregnancy took part. Researchers took blood and saliva samples to measure the drug levels and checked for side effects like high blood pressure or slowed growth. The goal was to gather information to make the treatment safer and more effective.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETINOPATHY OF PREMATURITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Sahlgrenska University Hospital

    Gothenburg, Västra Götaland County, 41685, Sweden

  • Skåne University Hospital

    Lund, Skåne County, 22185, Sweden

Conditions

Explore the condition pages connected to this study.